Business & Regulation

Why pharma and the high tech sector should band together for the sake of innovation.

Change is in the air for drug pricing in the US after the Senate passes the Inflation Reduction Act.

Ashfield Engage’s Ian Riches explains how companies can make patient engagement a priority.

ISCT’s new president talks platforms, regulation, and knowledge-transfer for the next generation

What difference can cloud-based systems make to data management?

Data management can be difficult but the right systems can help pharma manage the vast volumes of data it amasses.

What are the best locations for a pharma business to base entities when it comes to operating costs?

What difference will decentralized trials make to the future of clinical trials?

What happened at ISCT 2022’s return to in-person conferencing – and what can a new film release do for advanced therapy?

Why, oh why, is there so much nonsense and misinformation about COVID-19 vaccines?